Mobile-Health Network Solutions Reports H1 FY2025 Revenue Drop to $4.3M, Net Loss Widens to $1.7M

Reuters
06/16
Mobile-Health Network Solutions Reports H1 FY2025 Revenue Drop to $4.<a href="https://laohu8.com/S/MMM">3M</a>, Net Loss Widens to $1.7M

Mobile-health Network Solutions (Nasdaq: MNDR), a MedTech company based in Singapore, reported its financial results for the first half of fiscal year 2025, ending December 31, 2024. The company recorded a revenue of $4.3 million, a decrease from $6.6 million in the same period the previous year. The net loss was reported at $1.7 million, compared to a net loss of $1.5 million in H1 FY2024. The decline in revenue was attributed to reduced use of MNDR's telemedicine services following the closure of its CityGate clinic in Singapore, with a slight offset from increased sales of medicine and medical devices. Mobile-health Network Solutions has recently undertaken significant strategic changes, including the closure of its CityGate clinic to transition to a more asset-light business model focused on scalable, AI-driven virtual care. The company launched a tele-dentistry service in May 2025, enabling patients to conduct AI-enhanced dental scans at home. Additionally, the acquisition of Lifepack, a pharmacy and telehealth platform in Indonesia, positions MNDR to offer advanced telehealth-pharmacy solutions for Indonesia's market. Looking ahead, Mobile-health Network Solutions expects to achieve breakeven by the second half of fiscal year 2026 and aims for profitability before the first half of fiscal year 2027, as its recent initiatives begin to yield positive outcomes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mobile-Health Network Solutions published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-015142), on June 16, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10